Impact of Early Tumor Shrinkage and Depth of Response on the Outcomes of Panitumumab-Based Maintenance in Patients With RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Early Tumor Shrinkage and Depth of Response on the Outcomes of Panitumumab-Based Maintenance in Patients With RAS Wild-Type Metastatic Colorectal Cancer
Eur. J. Cancer 2021 Feb 01;144(xx)31-40, P Manca, S Corallo, G Randon, S Lonardi, C Cremolini, L Rimassa, F Bergamo, C Antoniotti, V Smiroldo, A Zaniboni, R Murialdo, M Tampellini, G Tomasello, M Clavarezza, P Racca, M Antista, A Raimondi, M Prisciandaro, F Pagani, F Palermo, FG Greco, M Vaiani, M Di Bartolomeo, F de Braud, G Calareso, F Morano, F PietrantonioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.